Category | Antibody level (units) | Odds ratio | 95% confidence interval | p-value (odds ratio) | p-value(linear trend) |
---|---|---|---|---|---|
Targeted side effects for both arms combined (mITT cohort) | |||||
Flu-like symptoms in past month | NAb ≥100 | 0.33 | (0.22, 0.48) | <0.001 | <0.001 |
NAb 20 to <100 | 0.41 | (0.28, 0.60) | <0.005 | ||
NAb <20 | 0.92 | (0.71, 1.18) | 0.50 | ||
BAb(−) | (Ref) | — | — | ||
Injection site reactions in past month | NAb ≥100 | 0.34 | (0.25, 0.45) | <0.001 | <0.001 |
NAb 20 to <100 | 0.59 | (0.41, 0.83) | 0.003 | ||
NAb <20 | 0.79 | (0.62, 1.01) | 0.062 | ||
BAb(−) | (Ref) | — | — | ||
Depression in past month | NAb ≥100 | 0.70 | (0.50, 0.99) | 0.046 | 0.083 |
NAb 20 to <100 | 0.99 | (0.68, 1.44) | 0.95 | ||
NAb <20 | 0.93 | (0.71, 1.22) | 0.60 | ||
BAb(−) | (Ref) | — | — |